Current challenges in personalized cancer medicine /

For this volume of Advances in Pharmacology we have brought together some of the foremost basic science and clinical researchers to discuss some of the new frontiers in the development of targeted cancer therapy. Although still in its formative stages, the development of targeted cancer therapies ha...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Smalley, Keiran
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Waltham, MA : Academic Press, 2012.
Σειρά:Advances in pharmacology ; 65.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03472nam a2200505 4500
001 ocn815477133
003 OCoLC
005 20180501122004.0
006 m o d
007 cr cn|||||||||
008 111102s2012 mau ob 001 0 eng d
040 |a E7B  |b eng  |e pn  |c E7B  |d OCLCO  |d N$T  |d OPELS  |d UPM  |d OCLCF  |d YDXCP  |d IDEBK  |d EBLCP  |d UKDOC  |d OCLCQ  |d ESU  |d OCLCQ  |d GrThAP 
019 |a 810318171  |a 817812439  |a 818862932  |a 823134306 
020 |a 9780123984838  |q (electronic bk.) 
020 |a 0123984831  |q (electronic bk.) 
020 |a 1283598094 
020 |a 9781283598095 
020 |a 9780123979278 
035 |a (OCoLC)815477133  |z (OCoLC)810318171  |z (OCoLC)817812439  |z (OCoLC)818862932  |z (OCoLC)823134306 
050 4 |a RC262  |b .C87 2012eb 
072 7 |a HEA  |x 039030  |2 bisacsh 
072 7 |a MED  |x 062000  |2 bisacsh 
082 0 4 |a 616.994  |2 23 
049 |a TEFA 
245 0 0 |a Current challenges in personalized cancer medicine /  |c edited by Keiran S.M. Smalley. 
260 |a Waltham, MA :  |b Academic Press,  |c 2012. 
300 |a 1 online resource (xviii, 558 pages). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Advances in pharmacology ;  |v 65 
504 |a Includes bibliographical references and index. 
520 |a For this volume of Advances in Pharmacology we have brought together some of the foremost basic science and clinical researchers to discuss some of the new frontiers in the development of targeted cancer therapy. Although still in its formative stages, the development of targeted cancer therapies has already shown incredible promise in a limited number of cancer types. As basic cancer research and drug development continues, we expect this number to grow and more patients to benefit from these exciting advances. Through better patient selection and novel strategies to manage resistance, a future can be envisaged in which cancer can be reduced to the level of a chronic, manageable disease. Brought together some of the foremost basic science and clinical researchers. Part of the renowned Advances in Pharmacology Serial Discussion of some of the new frontiers in the development of targeted cancer therapy. 
505 0 |a Front Cover; Current Challenges in Personalized Cancer Medicine; Copyright; Contents; Preface; Contributors; 2. MITOGENIC SIGNALING IN CANCER; 4. TARGETING OF PARALLEL SIGNALING PATHWAYS; 5. VERTICAL PATHWAY TARGETING; 7. CONCLUSION; ACKNOWLEDGMENTS; ABBREVIATIONS; ABBREVIATIONS; 1. INTRODUCTION; 3. TARGETING GLUCOSE METABOLISM; 3. THERAPIES TARGETING CELL ADHESION; 1. INTRODUCTION; ABBREVIATIONS; 1. INTRODUCTION; 1. INTRODUCTION; 6. CSCS IN SCC CLINICAL SAMPLES AND PROGNOSIS; 6. CONCLUSION; 1. INTRODUCTION; 3. THERAPEUTIC OVERVIEW; 1. INTRODUCTION; 1. INTRODUCTION; Index. 
650 0 |a Cancer  |x Treatment. 
650 0 |a Cancer  |x Diagnosis. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Cancer.  |2 bisacsh 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a Cancer  |x Diagnosis.  |2 fast  |0 (OCoLC)fst00845345 
650 7 |a Cancer  |x Treatment.  |2 fast  |0 (OCoLC)fst00845538 
655 4 |a Electronic books. 
700 1 |a Smalley, Keiran. 
776 0 8 |i Print version:  |a Smalley, Keiran.  |t Current Challenges in Personalized Cancer Medicine.  |d Burlington : Elsevier Science, ©2012  |z 9780123979278 
830 0 |a Advances in pharmacology ;  |v 65. 
856 4 0 |u https://www.sciencedirect.com/science/bookseries/10543589/65  |z Full Text via HEAL-Link